Nosocomial pneumonia

Česká verzia

Authors: Jana Skřičková
Authors place of work: Klinika nemocí plicních a TBC LF MU a FN Brno, pracoviště Bohunice
Published in the journal: Vnitř Lék 2017; 63(7-8): 518-526
Category: Reviews

Summary

Nosocomial pneumonia (hospital-acquired pneumonia – HAP) is the form of pneumonia the symptoms of which present after more than 2 days (> 48 hours) of admission to hospital or as late as 14 days of discharge from hospital. The HAP pneumonias represent 13–18 % of all nosocomial infections. Incidence of HAP is the most frequent in mechanically ventilated patients. The type and representation of HAP agents primarily depends on the length of a patient’s stay in hospital and on their condition and character of treatment. Diagnosing of pneumonia is based on anamnesis, physical and X-ray findings, results of examination of microbiological samples from the respiratory tract, hemoculture, the pleural effusion test, serological, hematological and biochemical tests. Antibiotic treatment is key to the comprehensive treatment of HAP. The HAP treatment always requires the dosing of antibiotics near the upper limit of the possible range. A precondition for successful avoidance of HAP pneumonias is the creation of a preventive programme with active engagement of medical staff.

Key words:
diagnostics – HAP pneumonia – treatment – ventilator-associated pneumonia

Zdroje

1. Jarvis WR. Nosocomial pneumonia. Marcel Dekker: New York – Basel 2000. IBSN 978–0824799427.

2. Cunha AB. Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia. Emedicine. Medscape Reference. Drugs &Diseases. 2017. Dostupné z WWW: <http://emedicine.medscape.com/article/234753-overview>.

3. Votava M, Jindrák V. Epidemiologie a etiologie nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165(7): 867–903.

5. Kollef MH, Morrow LE, Biederman MS et al. Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia. Chest 2006; 129(5): 1210–1218.

6. Carrabba M., Zarantolello M, Bonara P et al. Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression. Eur Respir J 2012; 40(5): 1201–1210. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00187811>.

7. Leroy O, Giradie P, Yaydapanah Y et al. Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens. Eur Respir J 2002; 20(2): 432–439.

8. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006; 130(2): 597–604.

9. Kollef MH, Morow LE, Niederman MS et al. Clinical Characteristics and Treatment Pattnerns Among Patients With Ventilator-Associated Pneumonia. Chest 2006; 129(5): 1210–1218. Erratum in Chest 2006; 130(1): 308.

10. Kornum JB, Norgaard M, Dethlefsen C et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010; 36(6): 1330–1336. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00184209>.

11. Chytra I, Ševčík P, Zvoníček V. Patogeneze, patofyziologie a rizikové faktory nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

12. Nseir R, Di Pompeo C, Jozefowicz E et al. Relationship between tracheostomy and ventilator-associated pneumonia: a case control study. Eur Respir J 2007; 30(2): 314–320.

13. [American Thoracic Society; Infectious Disease Society of America]. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healtcare associated Pneumonia. Am J Respir Crit Care Med 2005; 171(4): 388–416.

14. Skřičková J, Salajka F, Ševčík P. Anamnéza a fyzikální nález u zánětů plic. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

15. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: International Guidelines or Management of Severe Sepsis and Septic Shock: 2008. Crit Care Med 2008; 36(1): 296–327. Erratum in Crit Care Med 2008; 36(4):1394–1396.

16. Hausfater P, Garric S, Ben Ayed S et al. Usefulness of procalcitonin as a marker of Systemic infection in emergency department patients: a prospective study. CID 2002; 34(7): 895–901.

17. Decramer M, Roussos C. Imaging in lung disease. Eur Respir J 2002; 19(Suppl 35): 1–2.

18. Nebeský T. Zobrazovací metody v diagnostice pneumonií. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

19. Votava M, Jindrák V. Mikrobiologická diagnostika pneumonií a její interpretace. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

20. Skřičková J, Pavlík P. Odběry materiálnu na mikrobiologické vyšetření v diagnostice pneumonií. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

21. Bulpa PA, Dive AM, Mertens L et al. Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients. Eur Respir J 2003; 21(3): 489–494.

22. Papaziann L, Gainnier M. Indications of BAL, lung biopsy or both in mechanically ventilated patients with unexplained infiltrations. Eur Respir J 2003; 21(3): 383–384.

23. Jindrák V, Votava M. Úvodní antibiotická léčba zánětů plic – kritéria pro volbu antibiotika. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.

24. Rello J, Ulldemolins M, Lisboa T et al. Determinations of prescription and choice of empirical therapie for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 2011; 37(6): 1332–1339. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00093010>.

25. Jakubec P, Kolek V, Kolář M. Diagnostika a léčba těžké pneumonie. In: Kolek V et al. Doporučené postupy v pneumologii. 2nd ed. Maxdorf: Praha 2016. ISBN 978–80–7345–507–1.

26. Aarts MA, Hancock JN, Heyland D at al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials. Crit Care Med 2008; 36(1): 108–117.

27. Chytra I, Ševčík P, Votava M et al. Prevence nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80–7262–278–1.